118 devices · GMDN 53444
Apolipoprotein A-I (Apo A1) IVD reagents are laboratory chemicals designed to work with in vitro diagnostic (IVD) systems for measuring Apo A1 levels in blood or other clinical samples. These reagents help quantify Apo A1, a key protein linked to high-density lipoprotein (HDL) function, which plays a role in cholesterol transport and cardiovascular health assessment. Clinicians use these measurements to evaluate lipid profiles and risk factors for atherosclerosis or metabolic disorders. The reagents enable precise, standardized testing in clinical labs to support diagnostic decision-making.
These reagents are typically regulated as part of IVD systems and may require compliance with standards like ISO 13485 or FDA 21 CFR Part 820, depending on the jurisdiction. They are often supplied as kits or components for automated or manual assays, requiring validation for accuracy and reliability. Since they are not standalone devices but integral to diagnostic workflows, their classification and supply chain depend on the parent IVD system’s regulatory pathway. Always verify local requirements before use or distribution.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.